1.
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independe...
by Chan, Francis K L, Prof
The Lancet (British edition), 2017, Vol.389 (10087), p.2375-2382
2.
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
by Hochberg, Marc C Marc C
Annals of the rheumatic diseases, 2015, Vol.75 (1), p.37-44
3.
Evidence-based clinical practice guidelines for peptic ulcer disease 2015
by Satoh, Kiichi
Journal of Gastroenterology, 2016, Vol.51 (3), p.177-194
4.
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
by Asadabadi, Mahtab
Psychopharmacology, 2012, Vol.225 (1), p.51-59
5.
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT
by Sawitzke, Allen D
Annals of the rheumatic diseases, 2010, Vol.69 (8), p.1459-1464
6.
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (...
by Cannon, Christopher P
The Lancet (British edition), 2006, Vol.368 (9549), p.1771-1781
7.
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice
by Moore, R A
Annals of the rheumatic diseases, 2010, Vol.69 (2), p.374-379
8.
Effect of parecoxib sodium pretreatment combined with dexmedetomidine on early postoperative cognitive dysfunction in elderly patients after shoulder arthroscopy: A randomized doub...
by Lu, Jian
Journal of clinical anesthesia, 2017, Vol.41, p.30-34
9.
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions
by Wong, Benjamin C Y
Gut, 2012, Vol.61 (6), p.812-818
10.
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
by Baron, John A, Prof
The Lancet (British edition), 2008, Vol.372 (9651), p.1756-1764
11.
Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer
by Zhang, Hao
Phytomedicine (Stuttgart), 2014, Vol.21 (3), p.348-355
12.
Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma
by Daham, Kameran, MD, PhD
Journal of allergy and clinical immunology, 2014, Vol.134 (2), p.306-313
13.
Immunomodulatory therapy for severe influenza
by Darwish, Ilyse
Expert review of anti-infective therapy, 2011, Vol.9 (7), p.807-822
14.
Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial
by Fields, Cynthia, M.D
The American journal of geriatric psychiatry, 2012, Vol.20 (6), p.505-513
15.
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib
by Farkouh, M E
Annals of the rheumatic diseases, 2007, Vol.66 (6), p.764-770
16.
Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science
by Sahin, Ibrahim Halil
Cancer letters, 2013, Vol.345 (2), p.249-257
17.
A review of dexketoprofen trometamol in acute pain
by Hanna, Magdi
Current medical research and opinion, 2019, Vol.35 (2), p.189-202
18.
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of...
by Morales, Daniel R., MBChB
Journal of allergy and clinical immunology, 2013, Vol.134 (1), p.40-45.e10
19.
RNA-containing exosomes in induced sputum of asthmatic patients
by Sánchez-Vidaurre, Sara, PhD
Journal of allergy and clinical immunology, 2017, Vol.140 (5), p.1459-1461.e2
20.
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist
by Solomon, Daniel H
Annals of the Rheumatic Diseases, 2013, Vol.72 (11), p.1813-1818
